US FDA Tightens Global Oversight as Tariff Pressures Mount on Indian Pharma Exports
The FDA’s renewed focus on foreign inspections coincides with internal restructuring, including rehiring logistical support staff to manage the increase in site visits.
Tariff Pressures Mount On Indian Pharma Exports | 13/07/2025 | By Darshana | 172
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy